Mon, January 9, 2012
Sun, January 8, 2012
Sat, January 7, 2012
Fri, January 6, 2012
Thu, January 5, 2012
Wed, January 4, 2012
Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011
Thu, December 22, 2011
[ Thu, Dec 22nd 2011 ] - Market Wire
A View from the Top

PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call


//health-fitness.news-articles.net/content/2012/ .. r-2012-earnings-release-and-conference-call.html
Published in Health and Fitness on Tuesday, January 3rd 2012 at 6:55 GMT by Market Wire   Print publication without navigation


PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference... -- BOSTON, Jan. 3, 2012 /PRNewswire/ --

PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call

[ ]

BOSTON, Jan. 3, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: [ PRXL ]) will release financial results for the Second Quarter of Fiscal Year 2012 on Monday, January 30, 2012 after the close of the stock market.  The announcement will be available on PAREXEL's website at [ www.PAREXEL.com ] and on the PR Newswire website at [ www.prnewswire.com ].

PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Tuesday, January 31, 2012 to discuss the results.  To access the webcast, visit PAREXEL's website at [ www.PAREXEL.com ], and click on the Investors menu.  This webcast will continue to be accessible for one year following the live broadcast.  To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL's Second Quarter Fiscal Year 2012 conference call.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 67 locations throughout 52 countries around the world, and has approximately 10,850 employees.  For more information about PAREXEL International visit [ www.PAREXEL.com ].

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.

Contacts:
James Winschel, Senior Vice President and Chief Financial Officer
Jill Baker, Corporate Vice President, Investor Relations
+1-781-434-4118
Email: [ Jill.Baker@PAREXEL.com ]

SOURCE PAREXEL International Corporation

[ Back to top ]

RELATED LINKS
[ http://www.parexel.com ]


Publication Contributing Sources